After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Cara Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $0.99 and fluctuated between $1.0000 as its day high and $0.8900 as its day low. The current market capitalization of Cara Therapeutics Inc is $53.94M. A total of 0.59 million shares were traded on the day, compared to an average of 972.16K shares.
In the most recent transaction, Posner Christopher sold 5,834 shares of CARA for 0.89 per share on Feb 29 ’24. After the transaction, the PRESIDENT AND CEO now owns 180,521 company shares. In a previous transaction on Feb 29 ’24, Goncalves Joana sold 3,293 shares at 0.89 per share. CARA shares that CHIEF MEDICAL OFFICER owns now total 56,118.
Among the insiders who sold shares, Terrillion Scott disposed of 3,293 shares on Feb 29 ’24 at a per-share price of $0.89. This resulted in the SEC’Y; CHIEF COMPLIANCE & G.C. holding 91,000 shares of CARA after the transaction. In another insider transaction, Posner Christopher sold 35,575 shares at $0.53 per share on Feb 08 ’24. Company shares held by the PRESIDENT AND CEO now total 186,355.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CARA has a high of $10.28 and a low of $0.50.
As of this writing, CARA has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.35 per share and a lower estimate of -$0.44.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CARA’s latest balance sheet shows that the firm has $167.03M in Cash & Short Term Investments as of fiscal 2021. There were $3.67M in debt and $17.62M in liabilities at the time. Its Book Value Per Share was $1.57, while its Total Shareholder’s Equity was $227.52M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CARA is Buy with a score of 4.50.
